Obesity Surgery

, Volume 28, Issue 1, pp 262–263 | Cite as

The Forgotten Fundus—Response to - Obesity Treatment with Botulinum Toxin-A Is Not Effective: a Systematic Review and Meta-analysis

  • Dilhana S. Badurdeen
  • Lea Fayad
  • Anthony N. Kalloo
  • Vivek Kumbhari
Letter to the Editor



Botulinum toxin-A


Compliance with Ethical Standards

Conflicts of Interest

Anthony Kalloo is a founding Member, equity Holder, and consultant for Apollo Endosurgery.

Vivek Kumbhari is a consultant for Boston Scientific, Apollo Endosurgery, Medtronic, ReShape Medical, and Pentax Medical.

All other authors have no disclosures.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

Does not apply


  1. 1.
    Bustamante F, Brunaldi VO, Bernardo WM, et al. Obesity treatment with botulinum toxin-A is not effective: a systematic review and meta-analysis. Obes Surg. 2017.
  2. 2.
    Elshakh H, El-Ejji K, Taheri S. The role of endoscopic intra-gastric botulinum toxin-A for obesity treatment. Obes Surg. 2017.
  3. 3.
    Foschi D, Lazzaroni M, Sangaletti O, et al. Effects of intramural administration of botulinum toxin A on gastric emptying and eating capacity in obese patients. Dig Liver Dis. 2008;40(8):667–72. Scholar
  4. 4.
    García-Compean D, Mendoza-Fuerte E, Martínez JA, et al. Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study. Gastroenterologie Clinique Et Biologique. 2005;29(8–9):789–91.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Dilhana S. Badurdeen
    • 1
  • Lea Fayad
    • 1
  • Anthony N. Kalloo
    • 1
  • Vivek Kumbhari
    • 1
  1. 1.Division of Gastroenterology and HepatologyThe Johns Hopkins Medical InstitutionsBaltimoreUSA

Personalised recommendations